Desgadolinium Gadoteridol

• CAT Number: R044209
• CAS Number: 120041-08-9
• Molecular Formula: C17H32N4O7
• Molecular Weight: 404.464
• Purity: ≥95%
• Synonyms: 1,4,7-Tris(carboxymethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane; 10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid; HP-DO3A; USP Gadoteridol Related Compound A
• Storage: -20°C
• IUPAC Name: 2-[4,7-bis(carboxymethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
• InChI: InChI=1S/C17H32N4O7/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28)
• InChIKey: IQUHNCOJRJBMSU-UHFFFAOYSA-N
• SMILES: CC(CN1CCN(CCN(CCN(CC1)CC(=O)O)CC(=O)O)CC(=O)O)O

Desgadolinium gadoteridol is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI). It enhances the clarity of MRI scans by improving the contrast of internal body structures, aiding in the accurate diagnosis of various medical conditions. This compound is specifically designed to reduce the risk of gadolinium retention in the body, offering a safer alternative for patients requiring contrast-enhanced imaging. Its efficacy and safety make it a valuable tool in radiology.